Status:

COMPLETED

Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach

Lead Sponsor:

Washington University School of Medicine

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE1

Brief Summary

Although clinical decision tools (CDTs) exist for a variety of treatments, CDTs designed to support personalized breast reconstruction decisions, particularly about type and timing of reconstruction, ...

Eligibility Criteria

Inclusion

  • Newly diagnosed or recurrent breast cancer
  • Considering a referral or already referred to a plastic surgeon by their surgical oncologist for possible reconstruction
  • Considering or completing a mastectomy.
  • Does not have known distant metastatic disease (stage IV disease) at the time of recruitment
  • Female.
  • English-speaking.
  • At least 18 years of age.
  • Able to understand and willing to sign an IRB-approved written informed consent document.

Exclusion

    Key Trial Info

    Start Date :

    January 9 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 24 2018

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT03346161

    Start Date

    January 9 2018

    End Date

    October 24 2018

    Last Update

    September 6 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Washington University School of Medicine

    St Louis, Missouri, United States, 63110